日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

METTL7B-stabilized lncRNA-MIR22HG to drive p53-mediated neuronal apoptosis via the ubiquitinating JARID2 in cerebral ischemia/reperfusion injury.

METTL7B 稳定的 lncRNA-MIR22HG 通过泛素化的 JARID2 驱动 p53 介导的神经元凋亡,从而导致脑缺血/再灌注损伤。

Zhang Hao, Li Meng, Wu Yilin, Sun Xiaoou

[Retracted] MicroRNA‑155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2

[已撤稿] MicroRNA-155 通过靶向 ARID2 促进人肝细胞癌的肿瘤生长

Zhang, Li; Wang, Wei; Li, Xiaobin; He, Sai; Yao, Jianfeng; Wang, Xiaolong; Zhang, Di; Sun, Xuejun

Retraction: The Downregulation of GFI1 by the EZH2-NDY1/KDM2B-JARID2 Axis and by Human Cytomegalovirus (HCMV) Associated Factors Allows the Activation of the HCMV Major IE Promoter and the Transition to Productive Infection

撤稿:EZH2-NDY1/KDM2B-JARID2轴和人巨细胞病毒(HCMV)相关因子对GFI1的下调作用,使得HCMV主要IE启动子得以激活,并最终导致病毒感染的发生。

Synergistic targeting of the ARID2-MYC axis by pomalidomide and panobinostat overcomes intrinsic IMiD resistance in multiple myeloma.

泊马度胺和帕比司他协同靶向 ARID2-MYC 轴,克服多发性骨髓瘤固有的 IMiD 耐药性。

Yamamoto Junichi, Asatsuma-Okumura Tomoko, Ito Takumi, Iwai Yoshiko, Handa Hiroshi, Yamaguchi Yuki

Targeting the STK39/ARID2 Axis to Inhibit NF-κB Signaling: A Novel Pathway for Mesenchymal Stem Cell Osteogenic Differentiation in Osteoporosis Management.

靶向 STK39/ARID2 轴抑制 NF-κB 信号传导:间充质干细胞成骨分化治疗骨质疏松症的新途径。

Wang Yang, Wei Dong, Chen Zhineng, Zhong Liang

Genetic insights into sarcomatoid hepatocellular carcinoma: Critical role of ARID2 in pathogenesis and immune feature: Editorial on "Integrated molecular characterization of sarcomatoid hepatocellular carcinoma"

肉瘤样肝细胞癌的遗传学见解:ARID2 在发病机制和免疫特征中的关键作用:关于“肉瘤样肝细胞癌的整合分子特征”的社论

Nishida, Naoshi

ARID2-related disorder: further delineation of the clinical phenotype of 27 novel individuals and description of an epigenetic signature

ARID2相关疾病:进一步阐明27例新患者的临床表型并描述其表观遗传特征

Houdayer, Clara; Rooney, Kathleen; van der Laan, Liselot; Bris, Céline; Alders, Mariëlle; Bahr, Angela; Barcia, Giulia; Battault, Clarisse; Begemann, Anais; Bonneau, Dominique; Bonnevalle, Antoine; Boughalem, Aicha; Bourges, Alice; Bournez, Marie; Bruel, Ange-Line; Buhas, Daniela; Carallis, Floriane; Cogné, Benjamin; Cormier-Daire, Valérie; Delanne, Julian; Demaret, Tanguy; Denommé-Pichon, Anne-Sophie; Désir, Julie; Dubourg, Christèle; Fradin, Mélanie; Geneviève, David; Goel, Himanshu; Goldenberg, Alice; Gripp, Karen W; Guichet, Agnès; Guimier, Anne; Jacquinet, Adeline; Keren, Boris; Legoff, Louis; Levy, Michael A; McConkey, Haley; Mendelsohn, Bryce A; Mignot, Cyril; Milon, Vincent; Nizon, Mathilde; Oneda, Beatrice; Pasquier, Laurent; Patat, Olivier; Philippe, Christophe; Procaccio, Vincent; Procopio, Rebecca; Prouteau, Clément; Rambaud, Thomas; Rauch, Anita; Relator, Raissa; Rondeau, Sophie; Santen, Gijs W E; Schleit, Jennifer; Sorlin, Arthur; Steindl, Katharina; Tedder, Matt; Tessarech, Marine; Mau-Them, Frédéric Tran; Trost, Detlef; Van der Sluijs, Pleuntje J; Vincent, Marie; Whalen, Sandra; Thauvin-Robinet, Christel; Isidor, Bertrand; Sadikovic, Bekim; Vitobello, Antonio; Colin, Estelle

Alternative splicing of PBRM1 mediates resistance to PD-1 blockade therapy in renal cancer

PBRM1基因的选择性剪接介导肾癌对PD-1阻断疗法的耐药性

Namjoon Cho ,Seung-Yeon Kim ,Sung-Gwon Lee ,Chungoo Park ,Sunkyung Choi ,Eun-Mi Kim ,Kee K Kim

Correction: Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl

更正:双氢青蒿素通过 JARID2/miR-7/miR-34a 依赖性下调 Axl 来抑制前列腺癌

Paccez, Juliano D; Duncan, Kristal; Sekar, Durairaj; Correa, Ricardo G; Wang, Yihong; Gu, Xuesong; Bashin, Manoj; Chibale, Kelly; Libermann, Towia A; Zerbini, Luiz F

JARID2, a novel regulatory factor, promotes cell proliferation, migration, and invasion in oral squamous cell carcinoma

JARID2是一种新型调控因子,可促进口腔鳞状细胞癌的细胞增殖、迁移和侵袭。

Cheng, Yuxi; Song, Zhengzheng; Cheng, Jingyi; Tang, Zhangui